NCT00152867View on ClinicalTrials.gov

Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
CancerEmesisNausea
Interventions
DRUG

Dexamethasone

dexamethasone 4mg PO bd for 2 days post chemotherapy

Trial Locations (2)

M5G 2M9

Mount SinaiHospital, Toronto

Princess Margaret Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT00152867 - Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy | Biotech Hunter | Biotech Hunter